PCN79 - DECISION IMPACT OF A 21-GENE SIGNATURE IN EARLY BREAST CANCER: A NATURAL EXPERIMENT USING ROUTINE DATA (2018)
Attributed to:
Cost effectiveness of patient-matched pre- and on-treatment biomarkers in cancer therapy response prediction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2018.09.161
Publication URI: http://dx.doi.org/10.1016/j.jval.2018.09.161
Type: Journal Article/Review
Parent Publication: Value in Health